tetraethylenepentamine has been researched along with Liver Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hobara, T; Ishiyama, H; Kanbe, Y; Ogino, K; Shimomura, Y; Yamashita, S | 1 |
1 other study(ies) available for tetraethylenepentamine and Liver Diseases
| Article | Year |
|---|---|
The copper chelating agent tetraethylenepentamine inhibits copper, zinc-superoxide dismutase activity in rat liver: a possible mechanism for its hepatotoxicity.
Topics: Alanine Transaminase; Animals; Chelating Agents; Chemical and Drug Induced Liver Injury; Drug Administration Routes; Ethylenediamines; Glutathione; Liver; Liver Diseases; Male; Rats; Rats, Inbred Strains; Superoxide Dismutase; Trientine | 1991 |